This personalized assessment helps us weigh the potential benefits against any risks, ensuring that Tirzepatide is a safe option for you
Inform your doctor about any existing medical conditions, especially liver, kidney, or nerve-related disorders, before starting the tablet
Discuss transitioning to an FDA-approved medication
AGPAT, 1-acylglycerol-3-phosphate O-acyltransferase
You start seeing meaningful GIP-mediated effects around the 2 to 4 mg range, which is why the 4 mg dose group already showed impressive 17.1% weight loss at 48 weeks
Every compound in this class, from semaglutide to tirzepatide to these newer agents, causes nausea, vomiting, and diarrhea to some degree